Filtros de búsqueda

Lista de obras de Imam Waked

A comparative study of variants of pegylated interferon alpha in treatment of chronic HCV patients

artículo científico publicado en 2015

A life-sustaining single dose of recombinant activated factor VII for an Egyptian patient with hemorrhagic crisis

artículo científico publicado en 2007

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

artículo científico publicado en 2019

Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum.

artículo científico publicado en 2017

Analysis of long-term endoscopic surveillance during follow-up after variceal sclerotherapy from a 13-year experience

artículo científico publicado en 1997

Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging

artículo científico publicado en 2015

Association of Interleukin-27 rs 153109 Single Nucleotide Polymorphism with Spontaneous Resolution of Hepatitis C Virus - Genotype 4a Infection in Egyptian Patients

artículo científico publicado en 2016

Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians

scientific article published on 02 June 2018

Association of the Polymorphism of the Toll-like Receptor (TLR) 3 and TLR9 Genes with Hepatitis C Virus-Specific Cell-Mediated Immunity Outcomes Among Egyptian Healthcare Workers

scientific article published on 16 September 2020

Change in the hepatic profile of hepatitis C virus genotype 4-infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE-II study

Circulating AFP mRNA as a Possible Indicator of Hematogenous Spread of HCC Cells: A Possible Association with HBV Infection.

artículo científico publicado en 2007

Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt

artículo científico publicado en 2014

Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression

artículo científico publicado en 2016

Correction to Lancet Gastroenterol Hepatol 2019; 4: 454-65

artículo científico publicado en 2019

Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects

artículo científico publicado en 2014

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

artículo científico publicado en 2014

Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era.

artículo científico publicado en 2018

Diagnosis of hepatocellular carcinoma.

artículo científico publicado en 2009

Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma

artículo científico publicado en 2011

Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response

artículo científico publicado en 2015

Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients

scientific article published on 12 December 2020

Direct-acting antiviral drugs improve the female sexual burden associated with chronic HCV infection

artículo científico publicado en 2019

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

scientific article published on 04 April 2019

Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies

artículo científico publicado en 2015

Editorial: is sofosbuvir-based therapy suitable for patients with advanced chronic kidney disease?

artículo científico publicado en 2018

Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4.

artículo científico publicado en 2017

Efficacy and Safety of Basiliximab as Initial Immunosuppression in Liver Transplantation: A Single Center Study

artículo científico publicado en 2020

Elastography and serum markers of fibrosis versus liver biopsy in 1270 Egyptian patients with hepatitis C

scientific article published on 15 January 2020

Eliminating Hepatitis C within Low Income Countries - the need to cure Genotypes 4, 5, 6.

artículo científico publicado en 2017

Endoscopic Argon Plasma Coagulation for the Treatment of Portal Hypertensive Gastropathy ⬇️

artículo científico publicado en 2005

Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma.

artículo científico publicado en 2016

Estimating HCV disease burden-volume 4 (editorial).

artículo científico publicado en 2017

Female sexual dysfunction among Egyptian patients with chronic hepatitis C.

artículo científico publicado en 2013

GES: A validated simple score to predict risk of HCC in patients with HCV-GT4 associated advanced liver fibrosis after oral antivirals

artículo científico publicado en 2020

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt.

artículo científico publicado en 2017

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

artículo científico publicado en 2018

HCV treatment with direct acting antivirals improves the insulin sensitivity

artículo científico publicado en 2019

Health: redefined

scientific article published on 24 August 2018

Hepatic Schistosomiasis Post-Liver Transplantation ⬇️

artículo científico publicado en 2006

Hepatitis B and C Viral Markers among Family Members of Patients with Advanced Liver Disease and Occult Hepatitis B ⬇️

scholarly article

Hepatitis C Virus in Egypt: Interim Report From the World's Largest National Program

artículo científico publicado en 2019

Hepatitis C in Egypt - past, present, and future

artículo científico publicado en 2017

Hepatitis C infection in Egypt: prevalence, impact and management strategies

artículo científico publicado en 2017

Hepatitis C treatment: where are we now?

artículo científico publicado en 2017

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

artículo científico publicado en 2008

High Prevalence of Occult Hepatitis B in Patients with Advanced Liver Disease and Patients with Hepatitis C ⬇️

artículo científico publicado en 2005

High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

scientific article published on 23 June 2019

High efficacy of generic and brand direct acting antivirals in treatment of chronic hepatitis C

scientific article published on 02 August 2018

High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection

scientific article published on 13 August 2018

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

artículo científico publicado en 2014

Impact of COVID-19 on global hepatitis C elimination efforts

artículo científico publicado en 2020

Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection.

artículo científico publicado en 2013

Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians

artículo científico publicado en 2015

Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment

artículo científico publicado en 2019

Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections.

artículo científico publicado en 2005

Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians

artículo científico publicado en 2019

Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection

artículo científico publicado en 2015

Intermediate stage hepatocellular carcinoma: a summary review

artículo científico publicado en 2019

Khat-induced liver injuries: A report of two cases.

artículo científico publicado en 2016

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.

artículo científico publicado en 2018

Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL).

artículo científico publicado en 2008

Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients

artículo científico publicado en 2019

Long-term effect of mass chemotherapy of Schistosoma mansoni on infection rate and diagnosis accuracy.

artículo científico publicado en 2015

MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients.

artículo científico publicado en 2017

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care

artículo científico publicado en 2017

Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa

artículo científico publicado en 2020

Normal liver stiffness: A study in living donors with normal liver histology

artículo científico publicado en 2015

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.

artículo científico publicado en 2016

One step closer to elimination of hepatitis C in Egypt

artículo científico publicado en 2018

Optimal therapy in genotype 4 chronic hepatitis C: finally cured?

artículo científico

Planning and prioritizing direct acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience.

artículo científico publicado en 2017

Platelet-albumin-bilirubin score - a predictor of outcome of acute variceal bleeding in patients with cirrhosis

scientific article published on 01 March 2020

Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease

artículo científico publicado en 2017

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach

artículo científico publicado en 2019

Predictors of Early Rebleeding Following Endoscopic Control of Variceal Bleeding ⬇️

artículo científico publicado en 2005

Real Life Treatment of Hepatocellular Carcinoma: Impact of Deviation from Guidelines for Recommended Therapy

artículo científico publicado en 2015

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients

artículo científico publicado en 2016

Recent advances in multidisciplinary management of hepatocellular carcinoma

artículo científico publicado en 2015

Reply to 'Comment on 'Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion' '.

artículo científico publicado en 2017

Retreatment of hepatitis C virus: can it get any better?

scientific article published on 31 May 2018

Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre

artículo científico publicado en 2011

Role of hepatitis C infection in chronic liver disease in Egypt.

artículo científico publicado en 2002

Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patients

artículo científico publicado en 2014

Screening and Treatment Program to Eliminate Hepatitis C in Egypt

scientific article published on 01 March 2020

Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience.

artículo científico publicado en 2017

Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic Hepatitis

artículo científico publicado en 2006

Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis.

artículo científico publicado en 2016

Simple Predictive Model for Identifying Patients with Chronic Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High Probability of Sustained Virologic Response with Peginterferon Alfa-2a/Ribavirin: Pooled Analysis of Data from Two Large

artículo científico publicado en 2016

Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt.

artículo científico publicado en 2017

Sorafenib plus tegafur-uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

Strategies to manage hepatitis C virus (HCV) disease burden.

artículo científico publicado en 2014

The Plasma and Serum Metabotyping of Hepatocellular Carcinoma in a Nigerian and Egyptian Cohort using Proton Nuclear Magnetic Resonance Spectroscopy.

artículo científico publicado en 2017

The current and future disease burden of chronic hepatitis C virus infection in Egypt

artículo científico

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

artículo científico publicado en 2014

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

artículo científico publicado en 2017

Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post-therapeutic outcome and prognostic indicators

scientific article published on 01 April 2019

Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.

artículo científico publicado en 2011

Utility and cost-effectiveness of screening for hepatocellular carcinoma in a resource-limited setting.

artículo científico publicado en 2014

Utility of post-liver transplantation MELD and delta MELD in predicting early and late mortality.

artículo científico publicado en 2017

Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma

scientific article published on 01 June 2019

WITHDRAWN: Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy.

artículo científico publicado en 2013

What's in a name? Renaming "NAFLD'' to "MAFLD"

scientific article published on 17 April 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda